Evidence map›Paper›PMID 33300382›Full record

ArticleIntegrative cancer therapies

Acupuncture for Cancer Related Pain: Protocol for a Pragmatic Randomised Wait-List Controlled Trial.

Qi Zhao, Suyang Zheng, Geoff P Delaney, Eugene Moylan, Meera R Agar, Eng-Siew Koh, Hezheng Lai, Yoann Birling, George Shengxi Zhang, Kang Wang and 2 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Mixed methods research in complementary and alternative medicine: a scoping review.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Qi ZhaoDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Suyang ZhengChinese Medicine Centre, Western Sydney University, NSW, Australia.ORCID 0000-0001-8517-6002
Geoff P DelaneyUniversity of NSW, Australia.
Eugene MoylanSouth Western Sydney Local Health District, NSW, Australia.
Meera R AgarSouth Western Sydney Local Health District, NSW, Australia.
Eng-Siew KohSouth Western Sydney Local Health District, NSW, Australia.
Hezheng LaiChinese Medicine Centre, Western Sydney University, NSW, Australia.
Yoann BirlingChinese Medicine Centre, Western Sydney University, NSW, Australia.
George Shengxi ZhangChinese Medicine Centre, Western Sydney University, NSW, Australia.
Kang WangChinese Medicine Centre, Western Sydney University, NSW, Australia.
Yong MaNanjing University of Chinese Medicine, Nanjing, China.
Xiaoshu ZhuChinese Medicine Centre, Western Sydney University, NSW, Australia.
Western Sydney University · AUNanjing University of Chinese Medicine · CNSouth Western Sydney Local Health District · AUBeijing University of Chinese Medicine · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNUniversity of Technology Sydney · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcupuncture has been proved effective for cancer related pain (CRP) in China, America and some other countries. However, there is relative lack of evidence to support the use of acupuncture for CRP in Australia.

objectivesTo assess the effectiveness and safety of acupuncture for management of CRP in a real-world setting and to understand cancer patients' experience of undergoing acupuncture for CRP.

methodsA pragmatic randomised controlled trial will be conducted in South Western Sydney Local Health District (SWSLHD) in NSW, Australia. Adults with cancer related pain (n = 106) will be randomised in a 1:1 ratio to receive the acupuncture intervention up front versus after a wait list period of 4 weeks. Pain level (by Numerical Rating Scale), analgesic use, auricular acupressure frequency and adverse events will be assessed at baseline, mid-treatment and post-treatment. Expectancy on trial outcome (by Credibility and Expectancy questionnaire) will be assessed at baseline. The perspective of the participants (by an interview) will be recorded after the last intervention. EXPECTED OUTCOMES: We hypothesise that acupuncture will relieve cancer related pain at mid-treatment and post-treatment. We also hypothesise that few adverse events will be provoked by acupuncture.

trial registrationAustralia New-Zealand Clinical Trial Registry (ACTRN12620000325909).

Indexed as

AcupressureAcupuncture TherapyCancer PainNeoplasmsAdultAnalgesicsHumansPragmatic Clinical Trials as TopicRandomized Controlled Trials as TopicSurveys and QuestionnairesTreatment OutcomeAnalgesicsacupuncturecancer related painclinical trialcomplementary and alternative medicinepragmatic

Identifiers

PMID33300382
PMCPMC7734530
OpenAlexW3111731280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.